title: Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
abstract: The protein dystrophin is absent in muscles of patients with Duchenne muscular dystrophy (DMD) as well as in mdx mice. The mdx mouse diaphragm closely resembles the human DMD phenotype and should serve as an appropriate model for future studies of dystrophin gene replacement. In this regard, recombinant adenovirus (AV) holds great promise as a vector for delivering a functional dystrophin gene to muscle. However, the use of AV is hampered by the development of an immune response against transduced cells, resulting in short-lived transgene expression as well as possible adverse effects on organ function. In the present study, sensitive reporter genes were employed to determine the efficiency and functional consequences of AV-mediated gene transfer to the diaphragm in both normal and mdx adult mice. One week after direct intramuscular injection of AV into the diaphragm, the level of transgene expression was significantly increased in mdx compared with normal diaphragms. In addition, small-caliber fibers (< 500 microns2) demonstrated preferential transduction in both groups of mice. Normal diaphragms receiving AV exhibited a substantial reduction in maximal twitch and tetanic force generation, whereas no significant effect on diaphragm contractility was found in the mdx group at 1 wk after injection. At 1 mo after AV administration, however, there was a significant decrease in force production by both normal and mdx diaphragms. Immunosuppression with cyclosporine A over 1 mo did not augment the level of transgene expression, but a beneficial effect on diaphragm force-generating capacity was observed in both groups of animals. We conclude the following: (1) short-term transduction of the diaphragm is more efficient in mdx than in normal mice; (2) AV leads to reduced force production by the diaphragm, with this effect being more pronounced in normal than in mdx in the early (but not the late) postinjection period; and (3) immunosuppressive therapy with cyclosporine has a partially protective effect on muscle function after AV administration, which is apparently unrelated to sparing of transduced fibers from elimination by the host immune system. These findings have important implications for the application of AV-mediated dystrophin gene transfer to the treatment of DMD.
authors.affiliation: Department of Medicine, Royal Victoria Hospital, Montreal, Quebec, Canada.
authors.forename: B J
authors.initials: BJ
authors.lastname: Petrof
authors.forename: G
authors.initials: G
authors.lastname: Acsadi
authors.forename: A
authors.initials: A
authors.lastname: Jani
authors.forename: B
authors.initials: B
authors.lastname: Massie
authors.forename: J
authors.initials: J
authors.lastname: Bourdon
authors.forename: N
authors.initials: N
authors.lastname: Matusiewicz
authors.forename: L
authors.initials: L
authors.lastname: Yang
authors.forename: H
authors.initials: H
authors.lastname: Lochmüller
authors.forename: G
authors.initials: G
authors.lastname: Karpati
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics* / Q000472:pathogenicity; D000818:Animals; D016572:Cyclosporine / Q000494:pharmacology; D003964:Diaphragm; D016189:Dystrophin / Q000235:genetics*; D015870:Gene Expression; D015967:Gene Expression Regulation, Viral / Q000187:drug effects; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D007166:Immunosuppressive Agents / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D009119:Muscle Contraction; D009137:Muscular Dystrophy, Animal / Q000628:therapy*; D018995:Myosin Heavy Chains / Q000378:metabolism; D012038:Regeneration; D013997:Time Factors; D019076:Transgenes / Q000235:genetics
chemical_list: D016189:Dystrophin; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D018995:Myosin Heavy Chains